Valuation: Shandong Keyuan Pharmaceutical Co., Ltd.

Market Cap 5.12B 764M 678M 634M 578M 1.08B 73.56B 1.1B 7.66B 2.97B 37.47B 2.87B 2.81B 121B P/E 2024
53.4x
P/E 2025 195x
Enterprise Value 4.87B 727M 645M 603M 550M 1.03B 70.02B 1.05B 7.29B 2.82B 35.66B 2.73B 2.67B 115B EV / Sales 2024
6.15x
EV / Sales 2025 7.35x
Free-Float
41.05%
Yield 2024
0.67%
Yield 2025 0.17%
1 day-1.03%
1 week-5.50%
1 month+0.96%
3 months-4.16%
6 months+33.02%
Current year+61.26%
1 week 46.08
Extreme 46.08
49.59
1 month 44.78
Extreme 44.78
53.19
Current year 28.3
Extreme 28.3
59.24
1 year 25.87
Extreme 25.87
59.24
3 years 18.52
Extreme 18.52
59.24
5 years 18.52
Extreme 18.52
63.99
10 years 18.52
Extreme 18.52
63.99
Manager TitleAgeSince
President 47 2026-03-11
Director of Finance/CFO 44 2026-03-11
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 67 2015-09-05
Director/Board Member 66 2023-11-09
Chairman 41 2025-11-30
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-5.50%+37.47%+16.41% 763M
-0.62%-0.10%+50.70%+114.07% 1,031B
-2.30%-3.90%+39.50%+66.07% 638B
-0.63%-1.94%+12.26%+74.38% 462B
-1.03%-2.88%+71.35%+39.69% 359B
-0.03%-3.91%+34.28%+39.35% 335B
-1.58%+0.39%+17.92%+25.77% 273B
-2.02%-3.20%+7.60%+8.38% 253B
-3.38%+0.29%+44.32%+51.54% 228B
-1.04%-2.56%+32.88%+96.82% 185B
Average -0.69%-0.88%+34.83%+53.25% 376.46B
Weighted average by Cap. -0.24%-0.35%+38.05%+69.17%

Financials

2024 2025
Net sales 464M 69.23M 61.44M 57.42M 52.35M 98.26M 6.67B 99.92M 694M 269M 3.4B 260M 254M 10.94B 398M 59.45M 52.77M 49.31M 44.96M 84.38M 5.73B 85.81M 596M 231M 2.92B 223M 218M 9.39B
Net income 60.27M 9M 7.99M 7.46M 6.8M 12.77M 867M 12.99M 90.21M 34.94M 441M 33.78M 33.05M 1.42B 16.55M 2.47M 2.19M 2.05M 1.87M 3.51M 238M 3.57M 24.78M 9.6M 121M 9.28M 9.08M 391M
Net Debt -387M -57.76M -51.27M -47.9M -43.68M -81.98M -5.56B -83.37M -579M -224M -2.83B -217M -212M -9.13B -247M -36.83M -32.69M -30.55M -27.86M -52.28M -3.55B -53.16M -369M -143M -1.81B -138M -135M -5.82B
Logo Shandong Keyuan Pharmaceutical Co., Ltd.
Shandong Keyuan Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of chemical raw materials and preparations. The main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and isosorbide mononitrate. The products are used in the treatment of hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The Company also customizes chemical intermediates according to customer needs. The products are sold in both domestic and overseas markets.
Employees
650
Date Price Change Volume
26-09-30 CN¥47.25 -1.03% 1,590,083
26-09-29 CN¥47.74 +1.79% 1,427,645
26-09-28 CN¥46.90 -4.91% 2,417,283
26-09-24 CN¥49.32 -1.36% 2,576,582
26-09-23 CN¥50.00 -1.44% 1,854,675
  1. Stock Market
  2. Stocks
  3. 301281 Stock